Teva expects sales injection from U.S. EpiPen market

  • 📰 Reuters
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Teva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

We need insulin to drop

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Teva expects about 25 percent of EpiPen market by year-endTeva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...
Source: Reuters - 🏆 2. / 97 Read more »

Stocks making the biggest moves midday: Teva Pharmaceuticals, Hilton, Groupon & moreThese are the stocks posting the largest moves midday Wednesday.
Source: CNBC - 🏆 12. / 72 Read more »

Teva stock tumbles premarket as earnings and guidance fall short of estimatesHo ho I'm dead
Source: MarketWatch - 🏆 3. / 97 Read more »

Teva expects about 25 percent of EpiPen market by year-endTeva Pharmaceutical Industries expects its generic version of Mylan's EpiPe...
Source: Reuters - 🏆 2. / 97 Read more »

A US-China trade deal may not be the catalyst the market is expectingMarket strategists and policymakers are putting too much emphasis on a trade deal between the United States and China, and it's quite likely that whatever is agreed will disappoint. So it's going even higher? Sweet! Huge pop coming Tariffs make the dollar stronger and more jobs in America The redundancy in trading higher on the same headline is exhausting and manipulative. Real journalism please.
Source: CNBC - 🏆 12. / 72 Read more »